Literature DB >> 8245671

Parenteral single dose ceftriaxone with tinidatsole versus aminoglycoside with tinidatsole in colorectal surgery: a prospective single-blind randomized multicentre study.

M Matikainen1, K M Hiltunen.   

Abstract

A single dose preoperative antibiotic prophylaxis of ceftriaxone 2 g and tinidatsole 500 mg was compared with netilmycin (150 mg) or tobramycin (80 mg) in patients undergoing colorectal surgery by a prospective randomised single-blind trial. There were 628 patients from seven Finnish hospitals. The wound infection rate of 3% in the ceftriaxone group was significantly lower than 12% of the aminoglycoside group. Wound infection was related to the amount of perioperative blood loss, duration of the operation, type of operation and drainage in the aminoglycoside group. In the ceftriaxone group, wound infection was related to the patient's weight only.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245671     DOI: 10.1007/bf00341188

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  5 in total

1.  Perioperative infection prophylaxis in colon surgery.

Authors:  R Wohlfahrt; M Siedek
Journal:  Chemioterapia       Date:  1987-06

2.  Principles of antimicrobial prophylaxis.

Authors:  D W Burdon
Journal:  World J Surg       Date:  1982-05       Impact factor: 3.352

3.  The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds.

Authors:  P J Cruse; R Foord
Journal:  Surg Clin North Am       Date:  1980-02       Impact factor: 2.741

4.  [Plasma and tissue concentration of ceftriaxone following a one-time i.v. dose of 2 g].

Authors:  J C Küttel; P Petropoulos; C Crevoisier
Journal:  Schweiz Med Wochenschr       Date:  1988-05-21

Review 5.  The role of cephalosporins in surgical prophylaxis.

Authors:  S L Gorbach
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

  5 in total
  3 in total

Review 1.  Cost-effective prophylaxis of surgical infections.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

2.  A meta-analysis of randomized, controlled trials assessing the prophylactic use of ceftriaxone. A study of wound, chest, and urinary infections.

Authors:  J C Woodfield; N Beshay; A M van Rij
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

3.  Ceftriaxone versus Other Antibiotics for Surgical Prophylaxis : A Meta-Analysis.

Authors:  Silvano Esposito; Silvana Noviello; Alessandro Vanasia; Paola Venturino
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.